$144.2
Insights on Dr Horton, Inc.
Revenue is up for the last 2 quarters, 7.72B → 9.10B (in $), with an average increase of 15.2% per quarter
Netprofit is up for the last 2 quarters, 947.4M → 1.17B (in $), with an average increase of 19.2% per quarter
In the last 1 year, Toll Brothers Inc. has given 93.4% return, outperforming this stock by 55.6%
In the last 3 years, Pultegroup, Inc. has given 91.8% return, outperforming this stock by 46.3%
2.84%
Downside
Day's Volatility :3.26%
Upside
0.43%
30.9%
Downside
52 Weeks Volatility :39.89%
Upside
13.0%
Period | Dr Horton, Inc. | Sector (Consumer Discretionary) | S&P500 |
---|---|---|---|
3 Months | 3.21% | 1.5% | 3.7% |
6 Months | 45.16% | 17.7% | 22.6% |
1 Year | 35.03% | 21.2% | 25.0% |
3 Years | 45.52% | -2.5% | 21.1% |
Market Capitalization | 48.7B |
Book Value | $72.13 |
Dividend Share | 1.1 |
Dividend Yield | 0.81% |
Earnings Per Share (EPS) | 14.65 |
PE Ratio | 10.1 |
PEG Ratio | 0.6 |
Wall Street Target Price | 165.66 |
Profit Margin | 13.39% |
Operating Margin TTM | 16.35% |
Return On Assets TTM | 12.27% |
Return On Equity TTM | 22.09% |
Revenue TTM | 37.1B |
Revenue Per Share TTM | 110.59 |
Quarterly Revenue Growth YOY | 14.2% |
Gross Profit TTM | 8.9B |
EBITDA | 6.5B |
Diluted Eps TTM | 14.65 |
Quarterly Earnings Growth YOY | 0.29 |
EPS Estimate Current Year | 14.18 |
EPS Estimate Next Year | 15.42 |
EPS Estimate Current Quarter | 3.06 |
EPS Estimate Next Quarter | 3.92 |
What analysts predicted
Upside of 14.88%
FY18 | Y/Y Change | |
---|---|---|
Revenue | 16.1B | ↑ 14.03% |
Net Income | 1.5B | ↑ 40.63% |
Net Profit Margin | 9.09% | ↑ 1.72% |
FY19 | Y/Y Change | |
---|---|---|
Revenue | 17.6B | ↑ 9.49% |
Net Income | 1.6B | ↑ 10.83% |
Net Profit Margin | 9.2% | ↑ 0.11% |
FY20 | Y/Y Change | |
---|---|---|
Revenue | 20.3B | ↑ 15.45% |
Net Income | 2.4B | ↑ 46.66% |
Net Profit Margin | 11.69% | ↑ 2.49% |
FY21 | Y/Y Change | |
---|---|---|
Revenue | 27.8B | ↑ 36.74% |
Net Income | 4.2B | ↑ 75.92% |
Net Profit Margin | 15.03% | ↑ 3.34% |
FY22 | Y/Y Change | |
---|---|---|
Revenue | 33.5B | ↑ 20.54% |
Net Income | 5.9B | ↑ 40.27% |
Net Profit Margin | 17.5% | ↑ 2.47% |
FY23 | Y/Y Change | |
---|---|---|
Revenue | 35.5B | ↑ 5.92% |
Net Income | 4.7B | ↓ 18.98% |
Net Profit Margin | 13.38% | ↓ 4.12% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Revenue | 7.3B | ↓ 24.71% |
Net Income | 958.7M | ↓ 41.25% |
Net Profit Margin | 13.21% | ↓ 3.72% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Revenue | 8.0B | ↑ 9.85% |
Net Income | 942.2M | ↓ 1.72% |
Net Profit Margin | 11.82% | ↓ 1.39% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Revenue | 9.7B | ↑ 21.98% |
Net Income | 1.3B | ↑ 41.7% |
Net Profit Margin | 13.73% | ↑ 1.91% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Revenue | 10.5B | ↑ 8.0% |
Net Income | 1.5B | ↑ 13.08% |
Net Profit Margin | 14.37% | ↑ 0.64% |
Q4 FY23 | Q/Q Change | |
---|---|---|
Revenue | 7.7B | ↓ 26.45% |
Net Income | 947.4M | ↓ 37.25% |
Net Profit Margin | 12.26% | ↓ 2.11% |
Q1 FY24 | Q/Q Change | |
---|---|---|
Revenue | 9.1B | ↑ 17.88% |
Net Income | 1.2B | ↑ 23.72% |
Net Profit Margin | 12.87% | ↑ 0.61% |
FY18 | Y/Y Change | |
---|---|---|
Total Assets | 14.1B | ↑ 15.84% |
Total Liabilities | 5.0B | ↑ 11.69% |
FY19 | Y/Y Change | |
---|---|---|
Total Assets | 15.6B | ↑ 10.57% |
Total Liabilities | 5.3B | ↑ 7.18% |
FY20 | Y/Y Change | |
---|---|---|
Total Assets | 18.9B | ↑ 21.18% |
Total Liabilities | 6.8B | ↑ 27.85% |
FY21 | Y/Y Change | |
---|---|---|
Total Assets | 24.0B | ↑ 26.99% |
Total Liabilities | 8.8B | ↑ 29.58% |
FY22 | Y/Y Change | |
---|---|---|
Total Assets | 30.4B | ↑ 26.38% |
Total Liabilities | 10.6B | ↑ 20.07% |
FY23 | Y/Y Change | |
---|---|---|
Total Assets | 32.6B | ↑ 7.35% |
Total Liabilities | 9.4B | ↓ 10.61% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Total Assets | 30.3B | ↓ 0.29% |
Total Liabilities | 9.7B | ↓ 8.08% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 31.2B | ↑ 2.99% |
Total Liabilities | 10.0B | ↑ 3.47% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 32.3B | ↑ 3.7% |
Total Liabilities | 10.2B | ↑ 1.91% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 32.6B | ↑ 0.8% |
Total Liabilities | 9.4B | ↓ 7.78% |
Q4 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 33.4B | ↑ 2.45% |
Total Liabilities | 9.8B | ↑ 3.53% |
Q1 FY24 | Q/Q Change | |
---|---|---|
Total Assets | 34.4B | ↑ 3.05% |
Total Liabilities | 10.1B | ↑ 3.31% |
FY18 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 545.2M | ↑ 25.3% |
Investing Cash Flow | 2.6M | ↓ 101.52% |
Financing Cash Flow | -82.5M | ↓ 85.25% |
FY19 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 892.1M | ↑ 63.63% |
Investing Cash Flow | -394.0M | ↓ 15253.85% |
Financing Cash Flow | -490.1M | ↑ 494.06% |
FY20 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 1.4B | ↑ 59.35% |
Investing Cash Flow | -166.1M | ↓ 57.84% |
Financing Cash Flow | 270.6M | ↓ 155.21% |
FY21 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 534.4M | ↓ 62.41% |
Investing Cash Flow | -252.2M | ↑ 51.84% |
Financing Cash Flow | -85.1M | ↓ 131.45% |
FY22 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 561.8M | ↑ 5.13% |
Investing Cash Flow | -414.9M | ↑ 64.51% |
Financing Cash Flow | -811.2M | ↑ 853.23% |
FY23 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 4.3B | ↑ 666.13% |
Investing Cash Flow | -310.2M | ↓ 25.23% |
Financing Cash Flow | -2.7B | ↑ 228.74% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 829.1M | ↓ 26.28% |
Investing Cash Flow | -142.9M | ↑ 240.24% |
Financing Cash Flow | -646.6M | ↑ 233.3% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 644.5M | ↓ 22.27% |
Investing Cash Flow | -37.7M | ↓ 73.62% |
Financing Cash Flow | -144.7M | ↓ 77.62% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 787.5M | ↑ 22.19% |
Investing Cash Flow | -308.5M | ↑ 718.3% |
Financing Cash Flow | -326.2M | ↑ 125.43% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 2.0B | ↑ 159.43% |
Investing Cash Flow | -310.2M | ↑ 0.55% |
Financing Cash Flow | -1.5B | ↑ 374.92% |
Sell
Neutral
Buy
Dr Horton, Inc. is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.
Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
---|---|---|---|---|---|
Dr Horton, Inc. | -8.55% | 45.16% | 35.03% | 45.52% | 228.73% |
Nvr, Inc. | -1.38% | 45.02% | 35.51% | 58.2% | 147.9% |
Pultegroup, Inc. | -3.22% | 58.07% | 73.7% | 104.89% | 256.83% |
Lennar Corp. | -7.18% | 49.53% | 38.83% | 48.46% | 198.91% |
Toll Brothers Inc. | -5.71% | 74.15% | 93.45% | 91.82% | 217.13% |
Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
---|---|---|---|---|---|---|---|---|
Dr Horton, Inc. | 10.1 | 10.1 | 0.6 | 14.18 | 0.22 | 0.12 | 0.01 | 72.13 |
Nvr, Inc. | 16.92 | 16.92 | 4.89 | 494.13 | 0.4 | 0.2 | NA | 1371.5 |
Pultegroup, Inc. | 9.0 | 9.0 | 0.31 | 12.97 | 0.27 | 0.14 | 0.01 | 50.8 |
Lennar Corp. | 10.93 | 10.93 | 1.26 | 14.58 | 0.16 | 0.09 | 0.01 | 95.74 |
Toll Brothers Inc. | 9.26 | 9.26 | 0.94 | 13.72 | 0.21 | 0.09 | 0.01 | 67.29 |
Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
---|---|---|---|---|---|
Dr Horton, Inc. | Buy | $48.7B | 228.73% | 10.1 | 13.39% |
Nvr, Inc. | Buy | $24.0B | 147.9% | 16.92 | 16.67% |
Pultegroup, Inc. | Buy | $23.7B | 256.83% | 9.0 | 16.63% |
Lennar Corp. | Buy | $42.9B | 198.91% | 10.93 | 11.59% |
Toll Brothers Inc. | Buy | $12.5B | 217.13% | 9.26 | 13.97% |
Vanguard Group Inc
BlackRock Inc
Capital World Investors
State Street Corporation
Capital Research Global Investors
Bank of America Corp
In the quarter ending March,2024. Dr Horton, Inc. has declared dividend of $0.3
Read Mored.r. horton - america's builder d.r. horton is dedicated to building quality crafted, distinctive homes across the united states. the company has developed a reputation for high quality homes with features and amenities other builders often consider options or upgrades. the flexible home designs, attention to detail and affordable pricing are what make d.r. horton a national leader in the residential home building industry. donald r. horton began his own construction business in 1978 in the dallas/fort worth metroplex. in 1987, d.r. horton began expanding its operations by seeking out the nation's most active homebuilding markets. additionally, d.r. horton provides mortgage and title insurance services in many of its markets.
Organization | Dr Horton, Inc. |
Employees | 13450 |
CEO | Mr. Donald R. Horton |
Industry | Consumer Durables |
Spdr Portfolio Large Cap Etf
$144.20
-1.31%
Canadian National Railway Company
$144.20
-1.31%
Constellation Brands Inc.
$144.20
-1.31%
Live Nation Entertainment, Inc.
$144.20
-1.31%
Shopify Inc.
$144.20
-1.31%
Sirius Xm Holdings Inc.
$144.20
-1.31%
Corning Inc.
$144.20
-1.31%
Cummins Inc.
$144.20
-1.31%
Ishares Core U.s. Value Etf
$144.20
-1.31%